Abortion, Induced
Conditions
Brief summary
A randomized clinical trial to assess the effectiveness of same-day cervical preparation with oral, buccal or vaginal Misoprostol, given 2-4 hours prior first trimester curettage.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients admitted for elective first trimester abortion (termination of pregnancy/ missed abortion) at Wolfson Medical Center, gestational age \<13+0 weeks * Written consent supplied
Exclusion criteria
* Contraindications to prostaglandin treatment (severe asthma, glaucoma, severe cardiac disease, renal failure) * Prostaglandin allergy * Genital infection * Space-occupying lesion in the endocervical canal * Prior cervical surgery
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Preoperative cervical width in centimeters | intraoperative | • Initial cervical dilatation assessed by performing cervical dilatation , beginning with a number 10 Hegar dilator and subsequently inserting smaller Hegar dilators until the dilator can pass through the internal os without resistance. The largest one to pass will consist the initial cervical width. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Time required to achieve cervical dilatation | intraoperative | The time in minutes required for dilatation up to a number 10 Hegar |
| Ease of cervical dilatation | intraoperative | The subjective ease of cervical dilatation recorded by the surgeon on a 5-point Likert scale (1-very difficult, 5- very easy |
| Patient preference | baseline | Patient acceptability of the administration of medication on a 5-point Likert scale (1-very uncomfortable, 5-very comfortable) |
| Adverse effects of medication | baseline | Self reported misoprostol-associated adverse effects before the procedure (such as nausea, vomiting) |
| Surgical complications | intraoperative | Complications arising during surgery (perforation, cervical laceration, excess bleeding) |
Countries
Israel